Log in to save to my catalogue

CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Ins...

CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Ins...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808694616

CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series

About this item

Full title

CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series

Publisher

England: BMJ Publishing Group LTD

Journal title

Journal of clinical pathology, 2015-10, Vol.68 (10), p.844-848

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

BackgroundMantle cell lymphoma (MCL) is an aggressive disease with genetic heterogeneity and discrete clinical subtypes. MCL is rarely CD10 positive. These cases raise the question whether a subset of MCL may be germinal centre (GC) derived, and have distinct clinicopathological characteristics.Aims and methodsA series of nine CD10-positive MCL cas...

Alternative Titles

Full title

CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1808694616

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808694616

Other Identifiers

ISSN

0021-9746

E-ISSN

1472-4146

DOI

10.1136/jclinpath-2015-202955

How to access this item